News Articles Tagged: Leukemia Therapy Advances

Leveraging DOT1L Inhibitors: Advances in Leukemia Treatment Strategies

Discover how DOT1L inhibitors like EPZ-5676 (Pinometostat) are advancing leukemia treatment. Learn about their development and where to purchase these critical compounds.

Innovations in AML Care: The Promise of Venetoclax and Azacitidine for Long-Term Health

Examining the innovative use of Venetoclax and Azacitidine in intermediate-to-low-risk AML, focusing on improved survival and reduced recurrence rates through effective maintenance.